Serum immunoglobulin E levels in human immunodeficiency virus-infected children with pneumonia.
Elevated serum immunoglobulin E (IgE) levels have been reported in association with human immunodeficiency virus (HIV) infection in adults, but there is little information in children. The aim of the present study was to compare serum IgE levels in HIV-positive and -negative children hospitalized with pneumonia in South Africa and to investigate whether IgE may be useful as a marker of specific infections or prognosis in HIV-infected children. History, examination, blood tests, and induced sputum or bronchoalveolar lavage were carried out. Of 122 children [45% female, median age 8 months (3-20 months)], 81 were infected with HIV. A history of allergy or asthma was present in three children (two of whom were HIV positive). Serum IgE was higher in HIV-infected children [83 (33-147) vs. 29 (6-113) IU/l; p = 0.011] as was immunoglobulin G (IgG) [49 (37-63) vs. 27.5 (23-34) g/l; p < 0.001]. CD4 lymphocytes [600 (330-1,210) vs. 1,900 (1,500-3,030) cells/ micro l], percentage CD4 cells [13.6 (9.4-20.3) vs. 40.1 (31.1-44.9)] and CD4 : CD8 ratio [0.3 (0.2-0.4) vs. 2 (1.4-2.8)] were lower in HIV-positive children (p < 0.001 for all). Bacteremia occurred in 12 (10%) children; other specific pathogens identified included Mycobacterium tuberculosis in eight (7%) and Pneumocystis carinii in nine (7%). There was no correlation with CD4 count, CD4 : CD8 ratio, or the presence of specific pathogens, and IgE level. In-hospital mortality (11%) did not correlate with IgE levels. HIV-infected children with pneumonia have higher serum IgE compared with seronegative patients. In HIV-positive children, IgE levels did not correlate with the degree of immunosuppression or with outcome.
Zar
Heather J
HJ
Department of Paediatrics and Child Health, Red Cross Children's Hospital, University of Cape Town, Cape Town, South Africa. heather@rmh.uct.ac.za
Latief
Zeino
Z
Hughes
Jane
J
Hussey
Gregory
G
D016470:Bacteremia / Q000097:blood / Q000276:immunology / Q000401:mortality; D015415:Biomarkers / Q000097:blood; D003587:Cytomegalovirus; D004804:Eosinophils / Q000276:immunology; D005260:Female; D006678:HIV / Q000276:immunology*; D015658:HIV Infections / Q000097:blood* / Q000276:immunology* / Q000401:mortality; D018023:HIV Seronegativity / Q000276:immunology; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood* / Q000276:immunology*; D007074:Immunoglobulin G / Q000097:blood / Q000276:immunology; D007165:Immunosuppression Therapy; D007223:Infant; D007229:Infant Welfare; D007958:Leukocyte Count; D008297:Male; D011014:Pneumonia / Q000097:blood* / Q000276:immunology* / Q000401:mortality; D011446:Prospective Studies; D012720:Severity of Illness Index; D018139:Simplexvirus; D013019:South Africa; D016019:Survival Analysis; D014397:Tuberculosis, Pulmonary / Q000097:blood / Q000276:immunology / Q000401:mortality
D015415:Biomarkers; D007074:Immunoglobulin G; D007073:Immunoglobulin E